CONCORD MEDICAL - SPON ADR (CCM) Fundamental Analysis & Valuation

NYSE:CCM • US2062772049

Current stock price

3.65 USD
-0.05 (-1.35%)
Last:

This CCM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CCM Profitability Analysis

1.1 Basic Checks

  • CCM had negative earnings in the past year.
  • CCM had negative earnings in each of the past 5 years.
  • CCM had a negative operating cash flow in each of the past 5 years.
CCM Yearly Net Income VS EBIT VS OCF VS FCFCCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

  • The Return On Assets of CCM (-2.42%) is worse than 60.00% of its industry peers.
Industry RankSector Rank
ROA -2.42%
ROE N/A
ROIC N/A
ROA(3y)-5.89%
ROA(5y)-5.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CCM Yearly ROA, ROE, ROICCCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

  • CCM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CCM Yearly Profit, Operating, Gross MarginsCCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. CCM Health Analysis

2.1 Basic Checks

  • CCM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CCM has about the same amout of shares outstanding than it did 1 year ago.
  • CCM has about the same amout of shares outstanding than it did 5 years ago.
  • CCM has a worse debt/assets ratio than last year.
CCM Yearly Shares OutstandingCCM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CCM Yearly Total Debt VS Total AssetsCCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of -1.28, we must say that CCM is in the distress zone and has some risk of bankruptcy.
  • CCM has a Altman-Z score of -1.28. This is amonst the worse of the industry: CCM underperforms 84.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.28
ROIC/WACCN/A
WACC4.84%
CCM Yearly LT Debt VS Equity VS FCFCCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B

2.3 Liquidity

  • CCM has a Current Ratio of 0.42. This is a bad value and indicates that CCM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.42, CCM is not doing good in the industry: 89.00% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.41 indicates that CCM may have some problems paying its short term obligations.
  • CCM's Quick ratio of 0.41 is on the low side compared to the rest of the industry. CCM is outperformed by 89.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.41
CCM Yearly Current Assets VS Current LiabilitesCCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CCM Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 56.75% over the past year.
  • The Revenue for CCM has decreased by -22.46% in the past year. This is quite bad
  • Measured over the past years, CCM shows a quite strong growth in Revenue. The Revenue has been growing by 14.12% on average per year.
EPS 1Y (TTM)56.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.97%
Revenue 1Y (TTM)-22.46%
Revenue growth 3Y-7.53%
Revenue growth 5Y14.12%
Sales Q2Q%-8.22%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CCM Yearly Revenue VS EstimatesCCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CCM Yearly EPS VS EstimatesCCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 0 2 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. CCM Valuation Analysis

4.1 Price/Earnings Ratio

  • CCM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CCM Price Earnings VS Forward Price EarningsCCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CCM Per share dataCCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CCM Dividend Analysis

5.1 Amount

  • No dividends for CCM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CCM Fundamentals: All Metrics, Ratios and Statistics

CONCORD MEDICAL - SPON ADR

NYSE:CCM (3/24/2026, 8:18:12 PM)

3.65

-0.05 (-1.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)09-26
Earnings (Next)N/A
Inst Owners0.03%
Inst Owner Change-97.39%
Ins OwnersN/A
Ins Owner Change0%
Market Cap158.47M
Revenue(TTM)366.00M
Net Income(TTM)-163.00M
Analysts42.5
Price TargetN/A
Short Float %0.05%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.98
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.55
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.22
BVpS-7.48
TBVpS-10.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.42%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.89%
ROA(5y)-5.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.41
Altman-Z -1.28
F-ScoreN/A
WACC4.84%
ROIC/WACCN/A
Cap/Depr(3y)166.87%
Cap/Depr(5y)201.39%
Cap/Sales(3y)37.04%
Cap/Sales(5y)50.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.46%
Revenue growth 3Y-7.53%
Revenue growth 5Y14.12%
Sales Q2Q%-8.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.2%
OCF growth 3YN/A
OCF growth 5YN/A

CONCORD MEDICAL - SPON ADR / CCM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CONCORD MEDICAL - SPON ADR?

ChartMill assigns a fundamental rating of 0 / 10 to CCM.


What is the valuation status for CCM stock?

ChartMill assigns a valuation rating of 0 / 10 to CONCORD MEDICAL - SPON ADR (CCM). This can be considered as Overvalued.


Can you provide the profitability details for CONCORD MEDICAL - SPON ADR?

CONCORD MEDICAL - SPON ADR (CCM) has a profitability rating of 0 / 10.


Can you provide the financial health for CCM stock?

The financial health rating of CONCORD MEDICAL - SPON ADR (CCM) is 0 / 10.